Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Myomo Inc (NY: MYO )

3.165 +0.345 (+12.23%)
Streaming Delayed Price Updated: 3:34 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Myomo Inc

< Previous 1 2 3 Next >
Myomo Appoints Heather Getz to its Board of Directors
From Myomo, Inc.
Via Business Wire
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
From Myomo, Inc.
Via Business Wire
CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro®
From Myomo, Inc.
Via Business Wire
Myomo to Report Fourth Quarter Financial Results on March 7, 2024
From Myomo, Inc.
Via Business Wire
Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
From Myomo, Inc.
Via Business Wire
Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
From Myomo, Inc.
Via Business Wire
Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
From Myomo, Inc.
Via Business Wire
Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations
From Myomo, Inc.
Via Business Wire
CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting
From Myomo, Inc.
Via Business Wire
Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category
From Myomo, Inc.
Via Business Wire
Myomo to Report Third Quarter Financial Results on November 7, 2023
From Myomo, Inc.
Via Business Wire
Myomo Announces Closing of $4.4 Million Public Offering
From Myomo, Inc.
Via Business Wire
Myomo Announces Pricing of $4.4 Million Public Offering
From Myomo, Inc.
Via Business Wire
Myomo, Inc. Announces Proposed Public Offering
From Myomo, Inc.
Via Business Wire
Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims
From Myomo, Inc.
Via Business Wire
Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement
From Myomo, Inc.
Via Business Wire
Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics
From Myomo, Inc.
Via Business Wire
Myomo to Report Second Quarter Financial Results on August 9, 2023
From Myomo, Inc.
Via Business Wire
Centers for Medicare and Medicaid Services Accepts Myomo’s Application to Classify the MyoPro® as a Brace
From Myomo, Inc.
Via Business Wire
Myomo To Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest
From Myomo, Inc.
Via Business Wire
Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue
From Myomo, Inc.
Via Business Wire
Myomo to Report First Quarter Financial Results on May 10, 2023
From Myomo, Inc.
Via Business Wire
Myomo Receives Technology License Fee Payment from China Joint Venture Company
From Myomo, Inc.
Via Business Wire
Myomo Makes NYSE American Section 610(b) Public Announcement
From Myomo, Inc.
Via Business Wire
Myomo Reports Fourth Quarter and Full Year 2022 Financial Results
From Myomo, Inc.
Via Business Wire
Myomo to Report Fourth Quarter Financial Results on March 13, 2023
From Myomo, Inc.
Via Business Wire
Myomo To Participate in the 35th Annual Roth Conference
From Myomo, Inc.
Via Business Wire
MyoPro Approved in Australia by National Disability Insurance Scheme
From Myomo, Inc.
Via Business Wire
Myomo Appoints Yitzchak Jacobovitz to its Board of Directors
From Myomo, Inc.
Via Business Wire
Myomo Announces Closing of $6.5 Million Upsized Public Offering
From Myomo, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.